RECURSION PHARMACEUTICALS, INC. (RXRX) has 111 open-market insider trades by 10 insiders since 2021. The most active filer is Christopher Gibson, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mamoura Diversified Global Holding PJSC | 10% Owner | — | 10 | $68.8M | 2023-02-23 |
| Christopher Gibson | Dir | — | 44 | $26.4M | 2026-06-05 |
| Mubadala Investment Co PJSC | 10% Owner | — | 8 | $5.4M | 2023-03-02 |
| Blake Borgeson | Dir | — | 29 | $3.4M | 2026-10-06 |
| Lux Co-Invest Partners, LLC | 10% Owner | — | 1 | $1.8M | 2021-12-07 |
| Terry-Ann Burrell | Dir | — | 1 | $1.3M | 2024-07-01 |
| Shafique Virani | — | — | 7 | $981K | 2024-01-16 |
| Tina Marriott Larson | PresCOO | — | 7 | $910K | 2024-01-25 |
| Dean Y. Li | Dir | — | 2 | $689K | 2026-10-01 |
| Najat Khan | CEOPres | — | 2 | $499K | 2026-09-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Blake Borgeson | Director | Sell | $242K | 2026-10-06 |
| Robert Hershberg | Director | Sell | $125K | 2026-10-06 |
| Najat Khan | CEO & President | Sell | $79K | 2026-09-08 |
| Blake Borgeson | Director | Sell | $100K | 2026-09-01 |
| Blake Borgeson | Director | Sell | $98K | 2026-08-04 |
| Blake Borgeson | Director | Sell | $159K | 2026-07-07 |
Companies that share insiders with RXRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Namandje Bumpus | Director | Sell | $13K | 2026-06-18 |
| Najat Khan | CEO & President | Sell | $84K | 2026-06-05 |
| Christopher Gibson | Director | Sell | $145K | 2026-06-05 |
| Namandje Bumpus | Director | Sell | $16K | 2026-06-03 |
| Blake Borgeson | Director | Sell | $110K | 2026-06-02 |
| Christopher Gibson | Director | Sell | $123K | 2026-05-22 |
| Christopher Gibson | Director | Sell | $135K | 2026-05-07 |
| Blake Borgeson | Director | Sell | $106K | 2026-05-05 |
| Christopher Gibson | Director | Sell | $144K | 2026-04-22 |